Canada

Xagenic, a Toronto, Canada-based molecular diagnostics company developing the lab-free Xagenic X1™ platform for use at the point of care, raised CAD$15M in funding. Backers included Domain Associates, CTI Life Sciences, BDC Capital and the Ontario Capital Growth Corporation. The company intends to use the funds to accelerate its development efforts. Led by Timothy I. […]

USA

Sebacia, Inc., a Duluth, GA-based company dedicated to delivering dermatology treatments, completed a $22m Series C financing. The financing includes $12m in equity from existing investors, Accuitive Medical Ventures, Domain Associates, Versant Ventures, and Partners Innovation Fund, and $10m in a credit facility from Square 1 Bank. The company intends to use the funds to complete its pivotal […]

Canada

Milestone Pharmaceuticals Inc., a Saint-Laurent, Canada-based clinical stage cardiovascular company in Phase 2, closed a US$17m Series B financing. The round was led by Domain Associates with participation from existing investors Fonds de solidarité FTQ (FSTQ), Pappas Ventures, BDC Capital, GO Capital, and iNovia Capital. In connection with this financing, Domain’s Debra Liebert will join […]

USA

Obalon Therapeutics, Inc., a San Diego, California-based medical technology company, completed a $30m financing. This included a $20m Series D private equity financing from Axon Ventures, Bader Sultan & Bros. Co. W.L.L., Mirae Asset Venture Investment, NeoPlux Co., Ltd. and Striker Asia Opportunities Fund, and existing investors, Domain Associates, InterWest Partners and Okapi Venture Capital […]

USA

CoLucid Pharmaceuticals, a Durham, North Carolina-based developer of oral lasmiditan that treats migraine headaches, raised $37.1m in Series C funding. The round was led by TVM Capital Life Science with participation from Novo Ventures, Auriga Partners, Pappas Ventures, Domain Associates, Care Capital, Triathlon Medical Ventures and Pearl Street Ventures. In conjunction with the funding, Dr. […]

USA

BioNano Genomics, Inc., a San Diego, CA-based developer of a genome mapping platform, completed a $53m Series C financing. The round was co-led by Legend Capital and Novartis Venture Fund with participation from new investors Federated Kaufmann Fund and Monashee Investment Management and existing investors Domain Associates, Battelle Ventures and Gund Investment Corporation. In conjunction […]

USA

Colorescience, a Carlsbad, CA-based premier luxury mineral makeup company, completed a $15m Series B financing. The round was led by Longwood Fund with participation from existing investors including Hale BioPharma Ventures, Split Rock Partners, HealthCare Ventures, and Domain Associates, contributing $7.5m. In conjunction with the funding, Rich Aldrich of the Longwood Fund, joined Colorescience’s Board of Directors. The company intends to use […]

USA

Fractyl Laboratories, a Waltham, Mass.-based developer of a device-based endoscopic procedure to treat Type 2 diabetes, secured $40m in Series C funding. The round was led by Mithril with participation from General Catalyst, Bessemer Venture Partners and Domain Associates. In conjunction with the funding, Ajay Royan, Mithril’s co-founder and managing general partner, joined the company’s […]

USA

Epic Sciences, Inc., a San Diego, CA-based biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, completed a $30m Series C financing. Backers included new investors RusnanoMedInvest (RMI) and Arcus Ventures, existing investors Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, as well as undisclosed […]

fundingStart UpUSAventure capital

Otonomy, a San Diego, CA-based biopharmaceutical company developing therapeutics for diseases for the ear, secured $49m in Series D financing. Backers included new investors Jennison Associates LLC (on behalf of clients), Perceptive Advisors, Federated Kaufmann Funds, private investment funds advised by Clough Capital Partners LP, Ally Bridge Group, and additional undisclosed institutional investors as well […]

fundingStart UpUSAventure capital

Sequent Medical, a Aliso Viejo, California-based medical-device company, closed a $20.0m Series D venture capital financing. The round was led by existing investor Delphi Ventures with participation from existing investors Domain Associates, US Venture Partners, and Versant Ventures. The company intends to use the funds to continue to introduce the WEBTM Aneurysm Embolization System, including […]

fundingStart UpUSAventure capital

Lithera, a San Diego, Calif.-based a clinical stage pharmaceutical company, raised $8m in the final close of its Series C funding. This brought the total capital raised in this round to $35.6m. Backers included Alta Partners, Domain Associates, AKS Capital and other unnamed backers. The company intends to use the funds for general corporate and working […]

fundingUSAventure capital

Miramar Labs®, Inc., a Sunnyvale, CA-based medical device manufacturer focused on the treatment of excessive underarm sweat, raised $10m in Series D funding. Backers included Aisling Capital, Cross Creek Capital, Domain Associates, Morgenthaler Ventures, and RusnanoMedInvest. The company intends to use the capital expand sales activities around the world, support commercialization efforts in Europe given […]

fundingStart UpUSAventure capital

Atara Biotherapeutics, Inc., a Thousand Oaks, CA-based drug development company with a focus on innovative therapies for patients with debilitating diseases, held a $13.5m second closing of its recently announced Series B financing (read here). This additional tranche brought the total raised in the round to $52m. Backers in the Series B include Alexandria Venture Investments, […]

fundingStart UpUSAventure capital

Atara Biotherapeutics, Inc., a Thousand Oaks, CA-based drug development company with a focus on innovative therapies for patients with debilitating diseases, secured $38.5m in initial closings under its Series B financing. The transaction relates to three biotechnology entities: – Nina Biotherapeutics, Inc., – Pinta Biotherapeutics, Inc., and – Santa Maria Biotherapeutics, Inc. Backers included Amgen […]

CanadafundingStart Upventure capital

Xagenic Inc., a Toronto, Canada-based molecular diagnostics company, closed a $20m Series B financing. The round was led by new investor Domain Associates, LLC, with participation from existing investors CTI Life Sciences Fund and the Ontario Emerging Technologies Fund. In conjunction with the financing, Jesse Treu, PhD, Partner at Domain Associates, will join Xagenic’s Board […]

fundingStart UpUSAventure capital

RightCare Solutions, Inc., a Philadelphia, PA-based medical technology company, secured $5.0m in Series B funding. The round was led by existing investors Domain Associates, LLC and Compass Partners, LLC. The company intends to use the funds to expand its sales, marketing, and operations efforts. Led by Eric Heil, co-founder, President & CEO, RightCare Solutions provides […]

fundingStart UpUSAventure capital

NovaDigm Therapeutics, a Grand Forks, North Dakota-based developer of vaccines for fungal and bacterial infections, closed a $14m Series B financing. Backers included new investor RusnanoMedInvest and current investor Domain Associates. Led by Timothy Cooke, Ph.D., Chief Executive Officer, NovaDigm is developing NDV-3, a vaccine being developed for the treatment and prevention of infections caused […]